T he Prostate Imaging-Reporting and Data System (PI-RADS) was first published in 2012. The minimum acceptable technical parameters for multiparametric prostate magnetic resonance imaging (mpMRI) had been described in this document elaborately (1). In 2015, the PI-RADS guidelines were revised and version 2 (v2) was released. The technical specifications have been updated and acquisition recommendations for axial T2-weighted imaging, diffusion-weighted imaging (DWI), and dynamic contrast enhanced (DCE) imaging have been detailed in that edited version (2). Use of prostate MRI in prostate cancer has substantially increased (3), and prostate MRI is recognized as one of the biomarkers such as blood tests (e.g., serum prostate specific antigen [PSA], 4K test) and tissue based genomic classifiers (e.g., Oncotype DX, Decipher) (4). The biggest concern about prostate MRI as a potential biomarker amongst others is its inhomogeneous quality regarding image acquisition and interpretation (5, 6). Currently, only one study PURPOSE Although the clinical use of multiparametric prostate magnetic resonance imaging (mpMRI) is increasing, the adherence to parameters for mpMRI, which had been described in the Prostate Imaging-Reporting and Data System version 2 (PI-RADS v2) for an optimum image acquisition is unknown. In this paper, we aimed to determine the compliance with the minimum acceptable technical parameters for prostate mpMRI defined by PI-RADS v2 in tertiary care centers in Turkey.
has evaluated the adherence of imaging centers to the technical specifications of PI-RADS v2 (7) .
It has become a common practice to use MRI in healthcare all over the world in the last decade. Interestingly, based on 2015 data of the Organisation for Economic Cooperation and Development (OECD), Turkey is the country where the highest number of MRI scans (n=144 per 1000 individuals per year) were performed whereas corresponding numbers were 36 and 118 for the European Union (EU) and the United States (US), respectively. However, the number of MRI scanners per million was 10.2 in Turkey, whereas corresponding numbers were 13.7 and 39 for the EU and the US, respectively (8). While use of MRI has become more popular in clinical care in Turkey in the last decade, the share of prostate MRI within this workload is still unknown. On the other hand, localized prostate cancer care has already started to implement prostate MRI and few centers reported use of MRI and its guidance in targeted biopsies and surgery in Turkey (9) (10) (11) . In this study, we aimed to determine the compliance with the minimum acceptable technical parameters for prostate mpMRI defined by PI-RADS v2 in tertiary care reference centers in Turkey.
Methods
This retrospective study was approved by the ethics committee (approval number: 31829978-050.01.04-E.1800012835). We reached the radiology departments (n=120) of all third level referral hospitals in Turkey, including state university hospitals, training and research hospitals of the Ministry of Health, and private university hospitals by phone or mail in February 2018. We asked them to complete a survey form on mpMRI parameters, if prostate mpMRI was being performed in their departments (Table 1) . The responses were compared with PI-RADS v2 minimum acceptable technical parameters. Turkey's 2017 population data were received from the official website of the Turkish Statistical Institute (TSI) (12).
Statistical analysis
The comparison of field strength and institute types for the compliance with the parameters was done by chi-square and
Main points
• The adherence to MRI acquisition parameters of PI-RADS v2 is low in Turkey.
• Some recommendations of PI-RADS v2 for technical specifications may need to be revised.
• The image acquisition duration of T2-weighted imaging longer than 220 s can enhance the compliance with voxel size, which can potentially improve image quality. 
Results
One hundred and eleven of 120 clinics responded to our survey (response rate, 92.5%). Sixty-one of 111 (55%) centers reported to perform MRI of the prostate (59 centers multiparametric, 2 centers biparametric) (Fig. 1 ). 3 Tesla (T) scanner was used in 26 (42.6%), while 1.5 T scanner was used in 35 (57.4%) clinics (Fig. 2) . The vendors of MRI devices were Siemens in 35, Philips in 17 and General Electric in 9 clinics.
Thirty-three clinics (54.1%) were in the three largest cities of Turkey (Fig. 1) . MpMRI of the prostate was documented to be performed only in 13 of 59 cities with <1 million population according to 2017 data of TSI. Of the 61 centers performing prostate MRI, 36 were state universities, 14 were private universities, and 11 were training and research hospitals of the Ministry of Health.
The adherence to the minimum acceptable technical parameters of PI-RADS v2 is presented in Table 2 . The compliance with the parameters was as follows for T2-weighted imaging: slice thickness, 68.9%; inter-slice gap, 32.8%; field-of-view (FOV), 75.4%; inplane frequency resolution, 9.8%; in-plane phase resolution, 41%. The adherence to slice thickness, inter-slice gap, in-plane frequency, and phase resolution were higher in DWI compared with T2-weighted imaging and were 85.2%, 50.8%, 78.7%, and 62.3%, respectively. The compliance with FOV in DWI was 37.7% and there were 2 centers using narrower FOV than 160 mm, which is suggested as the lower limit in PI-RADS v2 (2). These 2 centers were considered to be incompatible with the PI-RADS v2 technical specifications. The adherence to highest b value ≥1400s/mm 2 was 57.4%. The adherence to slice thickness, inter-slice gap, inplane frequency, and phase resolution in DCE were 39%, 50.8%, 93.2%, and 89.9%, respectively. The adherence to temporal resolution ≤10 seconds (s) in DCE MRI was 55.9%. The mean acquisition times of axial T2-weighted imaging, DWI, and DCE imaging were 233, 274, and 247 s, respectively.
In comparative analysis, the adherence to slice thickness, FOV, and in-plane phase resolution at T2-weighted imaging were significantly higher for the centers using 3 T scanners (P = 0.004, P = 0.041, and P = 0.001, respectively). No significant difference was found regarding compliance with the other parameters between 1.5 T and 3 T scanners (Table 3) .
There was no significant difference between instutition types regarding compliance with any of the parameters. Mean durations of three major sequences were shorter in the private universities, but it was not statistically significant (Table 4) .
In comparison of acquisition times with the adherence to the minimum acceptable technical specifications, T2-weighted imaging acquisition time was significantly longer for the centers which adhered to FOV and in-plane phase resolution for T2-weighted imaging (P = 0.034 and P = 0.028, respectively) ( = 0.014 and P = 0.008, respectively) ( Table  6 ). The compliance with temporal resolution ≤10 s was also related with echo time (TE) and repetition time (TR) in DCE imaging (P = 0.011 for both).
In ROC analysis, the optimal cutoff value of T2 acquisition time was found as 220 s for adherence to voxel sizes (for phase: sensitivity 76%, specificity 69.4%, and area under the curve [AUC] 0.707; for frequency: sensitivity 83.3%, specificity 54.5%, and AUC 0.665). The cutoff value of DWI duration was calculated as 221 s (sensitivity 85.7%, specificity 65.4%, and AUC 0.74) for compliance with b value ≥1400s/mm 2 . When the cutoff time was taken as 312 s, sensitivity and specificity were found as 40% and 76.9%, respectively. The mean sequence duration of the centers which did not adhere to b value ≥1400s/mm 2 was 228 s, while it was 308 s for the centers meeting the b value criteria. The cutoff was calculated as 1.87 milliseconds (ms) for TE (sensitivity 100%, specificity 61.5%, and AUC 0.72) and 7.06 ms for TR (sensitivity 100%, specificity 15.4%, and AUC 0.553) to be able to comply with temporal resolution ≤10 s in DCE imaging.
Discussion
In this study, we found that the technical specifications of prostate mpMRI performed in tertiary referral centers in Turkey did not meet majority of the recommendations of PI-RADS v2. The lowest compliance was 9.8% in T2-weighted imaging frequency voxel size, while the highest one was 94.9% in TE and TR in DCE MRI. There was only one center meeting all technical specifications of PI-RADS v2. The minimum acceptable technical requirements was defined by expert consensus in PI-RADS v2 guidelines. There was no study focused on relation between image quality and technical specifications prior to release of PI-RADS v2. A previous study of Esses et al. (7) reported that the lowest compliance was 16.8% in T2-weighted imaging in-plane frequency dimension and the adherence to TE and TR were 100% in DCE MRI. In our study, adherence to the majority of the criteria was lower compared with that study except for some parameters such as temporal resolution, slice thickness, and inplane phase dimension in DCE MRI.
The PI-RADS v2 recommended to perform prostate mpMRI at 3 T scanners and suggested to use endorectal coil (ERC), especially when acquired at 1.5 T (2). While prostate MRI was more often performed with 1.5 T (59%) in Turkey, ERC was reported to be used only in 2 centers (one 3 T, one 1.5 T). In Esses et al. (7), 1.5 T scanners were used in 30.8% (23.1% without ERC, 7.7% with ERC) of 107 participant centers in the US.
The centers using 3 T more often adhered to slice thickness, FOV and in-plane dimension (phase) in T2-weighted imaging in our study. In the study of Esses et al. (7), the compliance with in-plane (phase) dimension of T2-weighted imaging, gap in DWI and in-plane (frequency) dimension in DCE MRI was also significantly higher with 3 T devices. Higher field strength scanners provide higher signal-to-noise ratio and this factor might have enabled higher number of matrix or narrower FOV.
In PI-RADS v2, the recommendations mainly focused on high spatial resolution, but there was no proposal for contrast resolution of any sequence. In our study, mean number of excitations (NEX) was 2.5 for T2-weighted imaging, whereas PI-RADS v2 did not make any suggestions. In the future versions of PI-RADS, NEX≥2 may be added for higher contrast resolution in T2-weighted imaging. The scan time is directly proportional to NEX, so careful checking of acquisition times may be important, and this can potentially enhance contrast resolution. In this context, use of 3 T scanners could be encouraged.
The PI-RADS v2 had no recommendation for acquisition times of T2-weighted imaging and DWI. In our study, 220 s was calculated as a cutoff value for T2-weighted imaging duration in order to comply with voxel dimensions. Also, the compliance with b value ≥1400 s/mm 2 was significantly higher for the centers acquiring DWI in 312 s or longer. These cutoffs may increase the adherence to voxel sizes in T2-weighted imaging and b value ≥1400 s/mm 2 in DWI. Temporal resolution should be at least ≤10 s and is preferred to be <7 s for DCE MRI in PI-RADS v2 (2) . The compliance with the 10 s criterion was 55.9%, while it was 16.9%
PI-RADS v2 compliance in multiparametric prostate MRI in Turkey Table 3 . Comparison of tertiary referral centers using 1.5 T and 3 T devices regarding compliance with the parameters of PI-RADS v2
Parameters/adherence 1.5 T (n=35), n (%) 3 T (n=26), n (%) P for 7 s criterion in our survey. The adherence to 7 s criterion was found as 9.6% in the study of Esses et al. (7) . Previous clinical studies suggested that a temporal resolution faster than 10 s does not provide any additional benefit in the diagnosis of the prostate cancer (13, 14) . Temporal resolution is directly related to the number of matrix (phase) and TR (15) . The adherence to TE and TR were relatively high (94.9%) in our study. Mean durations of the centers were 3.18 and 30 ms for TE and TR, respectively. The average durations of TE and TR were 1.62 and 4.44 ms for the centers with temporal resolution ≤10 s. The adherence to temporal resolution ≤10 s was higher when TE and TR was below 1.87 and 7.06 ms, respectively. Esses et al. (7) found mean TE and TR as 1.7 and 4.4 ms, respectively. The respective TE, TR, and temporal resolution values of previous studies on MRI of the prostate were as follows: 2.3 ms, 3.7 ms, 5.6 s; 1.89 ms, 4.1 ms, 2.3 s; and 1.96 ms, 5.5 ms, 3 s (16-18) . The PI-RADS v2 recommendations of TE <5 ms and TR <100 ms seem to be too long. In subsequent versions, shortening the TE and TR may be considered to improve the adherence to temporal resolution in DCE MRI.
The most important limitation of our study was that the data was based on the questionnaires and not on the actual DICOM data. It was assumed that all centers responded to our survey correctly. Another limitation was the inclusion of only tertiary referral centers, excluding private practice where mpMRI of the prostate is also being performed. Although the direct impact of adherence to PI-RADS technical standards on image quality is still unknown, our results can potentially assist others on which technical specifications among minimum acceptable technical parameters in PI-RADS guidelines should be further investigated to obtain good quality prostate MRI. Although the results may not be generalized to the entire clinical practice in Turkey, this is a relatively powerful survey with a high response rate of 92.5%. Larger scale studies evaluating the adherence to PI-RADS specifications in the entire world is needed, considering increasing popularity of the prostate MRI.
In conclusion, the adherence to voxel dimensions in T2-weighted imaging, b value ≥1400 s/mm 2 in DWI and temporal resolution <7 s in DCE were low in Turkey. The adherence to slice thickness, FOV, and in-plane dimension (phase) in T2-weighted imaging was higher when 3 T (vs. 1.5 T) scanners were used. Inclusion of recommendations regarding acquisition times and contrast resolution in the future versions of PI-RADS can potentially enhance the compliance with the technical specifications. Awareness to the minimum acceptable technical parameters of mpMRI can potentially improve the quality of pros- tate cancer imaging and future research is needed to explore impact of adherence to PI-RADS technical specifications on the resultant prostate MRI quality. 
